[go: up one dir, main page]

EP3515450A4 - Procédés et compositions pour la stimulation et l'accroissement de la régénération de tissus - Google Patents

Procédés et compositions pour la stimulation et l'accroissement de la régénération de tissus Download PDF

Info

Publication number
EP3515450A4
EP3515450A4 EP17853814.6A EP17853814A EP3515450A4 EP 3515450 A4 EP3515450 A4 EP 3515450A4 EP 17853814 A EP17853814 A EP 17853814A EP 3515450 A4 EP3515450 A4 EP 3515450A4
Authority
EP
European Patent Office
Prior art keywords
stimulation
regeneration
enhancement
tissues
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17853814.6A
Other languages
German (de)
English (en)
Other versions
EP3515450A1 (fr
Inventor
Michael Alan Zasloff
Viravuth Pho Yin
Kevin B. Strange
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mount Desert Island Biological Laboratory
Original Assignee
Mount Desert Island Biological Laboratory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/272,098 external-priority patent/US20170007624A1/en
Application filed by Mount Desert Island Biological Laboratory filed Critical Mount Desert Island Biological Laboratory
Publication of EP3515450A1 publication Critical patent/EP3515450A1/fr
Publication of EP3515450A4 publication Critical patent/EP3515450A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP17853814.6A 2016-09-21 2017-09-20 Procédés et compositions pour la stimulation et l'accroissement de la régénération de tissus Withdrawn EP3515450A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/272,098 US20170007624A1 (en) 2012-12-20 2016-09-21 Methods and compositions for stimulation and enhancement of regeneration of tissues
PCT/US2017/052516 WO2018057624A1 (fr) 2016-09-21 2017-09-20 Procédés et compositions pour la stimulation et l'accroissement de la régénération de tissus

Publications (2)

Publication Number Publication Date
EP3515450A1 EP3515450A1 (fr) 2019-07-31
EP3515450A4 true EP3515450A4 (fr) 2020-07-29

Family

ID=61689739

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17853814.6A Withdrawn EP3515450A4 (fr) 2016-09-21 2017-09-20 Procédés et compositions pour la stimulation et l'accroissement de la régénération de tissus

Country Status (4)

Country Link
EP (1) EP3515450A4 (fr)
JP (1) JP2019529558A (fr)
CA (1) CA3037712A1 (fr)
WO (1) WO2018057624A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101799214B1 (ko) * 2016-12-01 2017-11-20 재단법인 전남생물산업진흥원 모새나무 열매 추출물을 포함하는 우울증 예방 및 개선용 건강기능성 식품조성물
US20230248781A1 (en) * 2020-07-08 2023-08-10 Beijing Rongxiang Institute Of Regenerative Medicine Co., Ltd. Method for regulating expression level of musashi1 in cells

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000009137A2 (fr) * 1998-08-12 2000-02-24 Magainin Pharmaceuticals, Inc. Composes aminosteroliques et utilisations correspondantes
US20010046521A1 (en) * 1996-04-26 2001-11-29 Michael Zasloff Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
EP1639097B1 (fr) * 2003-06-25 2013-08-07 Ottawa Health Research Institute Procedes et compositions pour moduler la croissance et la differentiation des cellules souches
SG177143A1 (en) * 2006-11-01 2012-01-30 Univ Rutgers Lithium stimulation of cord blood stem cell proliferation and growth factor production
WO2010011185A1 (fr) * 2008-07-21 2010-01-28 Agency For Science, Technology And Research Cellules souches obtenues par culture in vitro avec du sulfate d'héparane
JP6434916B2 (ja) * 2012-12-20 2018-12-05 マウント デザート アイランド バイオロジカル ラボラトリー 組織の再生の刺激および促進
US20170007624A1 (en) * 2012-12-20 2017-01-12 Mount Desert Island Biological Laboratory Methods and compositions for stimulation and enhancement of regeneration of tissues

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010046521A1 (en) * 1996-04-26 2001-11-29 Michael Zasloff Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
WO2000009137A2 (fr) * 1998-08-12 2000-02-24 Magainin Pharmaceuticals, Inc. Composes aminosteroliques et utilisations correspondantes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NORBERT VIDA ET AL: "Polyamine conjugates of stigmasterol", STEROIDS, vol. 77, no. 12, 28 July 2012 (2012-07-28), pages 1212 - 1218, XP055060720, ISSN: 0039-128X, DOI: 10.1016/j.steroids.2012.07.009 *
See also references of WO2018057624A1 *

Also Published As

Publication number Publication date
EP3515450A1 (fr) 2019-07-31
CA3037712A1 (fr) 2018-03-29
WO2018057624A1 (fr) 2018-03-29
JP2019529558A (ja) 2019-10-17
WO2018057624A4 (fr) 2018-05-17

Similar Documents

Publication Publication Date Title
EP3490581A4 (fr) Compositions neuromodulatrices et méthodes associées de traitement du cancer
EP3668993A4 (fr) Procédés de traitement de maladies hépatiques
EP3233047A4 (fr) Compositions et procédés permettant d'améliorer l'aspect de la peau
EP3177732A4 (fr) Compositions et procédés pour le traitement de maladies et états pathologiques ophthalmiques
EP3185876A4 (fr) Compositions et procédés de traitement de troubles neurologiques
EP3212226A4 (fr) Compositions et leurs méthodes d'utilisation pour le traitement de troubles métaboliques
EP3242672A4 (fr) Composition thérapeutique dérivée d'amnios et son procédé de production
EP3174894A4 (fr) Compositions et méthodes d'utilisation pour le traitement de troubles métaboliques
EP3283061A4 (fr) Compositions et méthodes de traitement de troubles du sein et de troubles liés aux strogènes
EP3096617A4 (fr) Compositions et méthodes de traitement de maladies oculaires
EP3285782A4 (fr) Procédés de réparation et de régénération de tissus
EP3429584A4 (fr) Compositions et méthodes de traitement de la presbytie
EP3139928A4 (fr) Compositions d'anordrine et méthodes de traitement de maladies
EP3151786A4 (fr) Compositions et procédés de régénération de tissus durs
EP3131556A4 (fr) Méthodes et compositions pour le traitement de maladies liées à la bpco
EP3240577A4 (fr) Procédés et compositions de traitement de maladies cérébrales
EP3389620A4 (fr) Compositions de stimulation de cellules souches et procédés de traitement du mélasma
EP3185910A4 (fr) Méthodes et compositions pour le traitement du cancer
EP3154952A4 (fr) Méthodes et compositions pour traiter les cancers her positifs
EP3134108A4 (fr) Agents et procédés de traitement
EP3258908A4 (fr) Compositions et méthodes de traitement d'infections cutanées
EP3265103A4 (fr) Compositions et méthodes de traitement de maladies oculaires
ZA201900984B (en) Methods and compositions for the treatment of warts
EP3515450A4 (fr) Procédés et compositions pour la stimulation et l'accroissement de la régénération de tissus
EP3496696A4 (fr) Composés et méthodes pour traiter la maladie.

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190320

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 45/06 20060101ALI20200319BHEP

Ipc: A61P 21/00 20060101ALI20200319BHEP

Ipc: A61P 43/00 20060101ALI20200319BHEP

Ipc: A61K 31/575 20060101AFI20200319BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20200625

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 21/00 20060101ALI20200619BHEP

Ipc: A61K 45/06 20060101ALI20200619BHEP

Ipc: A61P 43/00 20060101ALI20200619BHEP

Ipc: A61K 31/575 20060101AFI20200619BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210126